Loading...
HomeMy WebLinkAbouterm-cal-anr-sharps-revised-v0-20210401-archive 2020 MED-Project Annual Report County of Alameda, California Sharps March 1, 2021 Revised April 1, 2021 Prepared By: MED-Project LLC Submitted To: Alameda County Department of Environmental Health 2 Table of Contents I. Executive Summary ................................................................................................. 4 II. Participating Producers .......................................................................................... 5 III. Sharps Collection Method and Weight .................................................................. 5 A. Kiosks .................................................................................................................... 5 B. Mail-Back Services ................................................................................................... 5 C. Take-Back Event ..................................................................................................... 5 D. Total Weight of Collected Sharps .............................................................................. 5 IV. Sharps Collection Weight ...................................................................................... 5 V. Sharps Kiosk Drop-Off Site Locations ..................................................................... 5 VI. Mail-Back Services................................................................................................. 6 VII. Take-Back Events ................................................................................................. 6 VIII. Disposal and Transporter Information ............................................................... 6 A. Transporter Information........................................................................................... 6 B. Disposal Facility Information..................................................................................... 6 IX. Safety and Security Report .................................................................................... 6 X. Educational Efforts and Public Outreach ................................................................. 6 A. Public Education Activities ........................................................................................ 6 B. Outreach Activities .................................................................................................. 7 C. Evaluation Activities ................................................................................................. 7 XI. Program Goals ....................................................................................................... 7 A. Summary of Product Stewardship Plan’s Goals ........................................................... 7 XII. Expenditures ........................................................................................................ 8 Appendix A ................................................................................................................11 List of Participating Producers .......................................................................................11 Appendix B ................................................................................................................18 Sharps Kiosk Collection Data .........................................................................................18 Appendix C ................................................................................................................21 Sharps Household Hazardous Waste Facilities ................................................................21 Appendix D ................................................................................................................22 Sharps Mail-Back Services ............................................................................................22 Appendix E ................................................................................................................23 Sharps Take-Back Event ...............................................................................................23 3 Appendix F ................................................................................................................24 Transporters ...............................................................................................................24 Appendix G ................................................................................................................25 Disposal Facilities .........................................................................................................25 Appendix H ................................................................................................................26 Safety and Security Report ...........................................................................................26 Appendix I ................................................................................................................27 MED-Project Website Pages ..........................................................................................27 Appendix J ................................................................................................................36 Website Statistics ........................................................................................................36 Appendix K ................................................................................................................37 MED-Project Sharps Brochures and Posters ....................................................................37 Appendix L ................................................................................................................52 Brochure and Poster Distribution ...................................................................................52 Appendix M ...............................................................................................................53 Social Media and Promotion Activity ..............................................................................53 Social Media Posts .......................................................................................................53 Email Blast Activity.......................................................................................................58 Appendix N ................................................................................................................59 Media Outreach Summary ............................................................................................59 4 I. Executive Summary MED-Project LLC (“MED-Project”) operates a Product Stewardship Plan for Sharps from Households (“Plan”) in the County of Alameda (“Jurisdiction”) under the Alameda County Safe Consumer-Generated Sharps Disposal Ordinance No. 2015-53, Alameda Municipal Code Chapters 6.54.010 – 6.54.180 (“Ordinance”). This 2020 County of Alameda Annual Sharps Report (“Report”) describes the activities of MED-Project frp, January 1, 2020, to December 31, 2020 (“Reporting Period”) in compliance with Ordinance Section 6.54.120. All capitalized terminology not defined in this annual report is derived from the approved Plan dated January 31, 2018, as amended on March 26, 2018. During the Reporting Period, MED-Project operated its Product Stewardship Program (“Program”) and collected Sharps in accordance with the Plan, as approved by the Alameda County Department of Environmental Health (“Department”) on March 26, 2018. On February 29, 2020, MED-Project requested the use of an additional disposal facility. On April 16, 2020, the Department approved the request. MED- Project sent the Jurisdiction an initial COVID-19 response notification on March 17, 2020, and a second notification with additional information on March 26, 2020. On April 15, 2020, MED-Project provided a third COVID-19 response notification, including then-current information on restricted access to sites. On July 16, 2020 MED-Project provided a fourth COVID-19 response notification, including then-current information on restricted access to sites. On November 13, 2020, MED-Project submitted a fifth COVID- 19 response notification, which indicated that only six sites in the Jurisdiction remained restricted. See Table 2; Sharps Kiosk Collection Data for all sites that were restricted during the Reporting Period. During 2020, MED-Project gave priority to establishing Sharps Kiosk Drop-Off Sites throughout Alameda County, conducting a Take-Back Event in alignment with approved Plan goals, and performing outreach to eligible pharmacies, community organizations, local government agencies, health associations, and Law Enforcement Agencies (“LEAs”) throughout Alameda County. As a result of these efforts, MED- Project’s Program collected and disposed of “Sharps” (as defined in Plan Section V) from 38 Sharps Kiosk Drop-Off Sites, four Household Hazardous Waste Facilities, residential Mail-Back Services, and one Take- Back Event in 2020. Sharps kiosks were installed in pharmacies and LEAs that met all local, state, and federal requirements and that executed agreements with MED-Project. In addition, outreach and educational materials were distributed upon request and to all newly activated Sharps Kiosk Drop-Off Sites, including signage and/or brochures. MED-Project continues to communicate with Sharps Kiosk Drop-Off Site Hosts participating in the Program to coordinate and monitor implementation as well as ensure materials for Residents are available at all participating Sharps Kiosk Drop-Off Sites. As outlined in the approved Plan, the ultimate goal of the Program is to provide Alameda County Residents with convenient, safe, and accessible methods to dispose of Sharps. MED-Project anticipates a steady increase in Sharps Kiosk Drop-Off Sites throughout 2021 as a result of outreach, educational, and promotional Program activities, especially if there is an increase in retail chain pharmacy participation. The following Sections of the Report address the specific reporting requirements in Ordinance Section 6.54.120. Each section of the Report restates the corresponding Ordinance requirement and provides the required information. 5 II. Participating Producers Ordinance Sec. 6.54.120.A.1: “A list of Producers participating in the Product Stewardship Plan.” See Appendix A; List of Participating Producers. III. Sharps Collection Method and Weight Ordinance Sec. 6.54.120.A.2: “The amount, by weight, of Sharps collected, including the amount by weight from each collection method used.” A. Kiosks − MED-Project collected 26,356 pounds of Sharps through Kiosk Drop-Off Sites. − MED-Project collected 13,395 pounds of Sharps through Household Hazardous Waste Locations. See Appendix B; Sharps Kiosk Collection Data. See Appendix C; Sharps Household Hazardous Waste Facilities. B. Mail-Back Services − MED-Project collected 207.7 pounds of Sharps through Mail-Back Services. See Appendix D; Sharps Mail-Back Services. C. Take-Back Event − MED-Project collected 163 pounds directly from Residents at the Take-Back Event. See Appendix E; Sharps Take-Back Event. D. Total Weight of Collected Sharps − MED-Project collected a total of 40,121.7 pounds of Sharps through all methods. IV. Sharps Collection Weight Ordinance Sec. 6.54.120.A.3: “The weight of Sharps collected and number of pickups, and the quantity of outer containers (if applicable), for each collection site.” See Appendix B; Sharps Kiosk Collection Data. See Appendix C; Sharps Household Hazardous Waste Facilities. V. Sharps Kiosk Drop-Off Site Locations Ordinance Sec. 6.54.120.A.4: “A list of drop-off sites.” See Appendix B; Sharps Kiosk Collection Data. See Appendix C; Sharps Household Hazardous Waste Facilities. 6 VI. Mail-Back Services Ordinance Sec. 6.54.120.A.5: “The number of mail-back containers provided to County residents, and how many were returned during the reporting period.” − MED-Project distributed 357 Sharps mail-back packages directly to Residents. − MED-Project received 60 returned Sharps mail-back packages. See Appendix D; Sharps Mail-Back Services. VII. Take-Back Events Ordinance Sec. 6.54.120.A.6: “The dates and locations of collection events held, if applicable, and the quantities by weight returned at those events.” See Appendix E; Sharps Take-Back Event. VIII. Disposal and Transporter Information Ordinance Sec. 6.54.120.A.7: “The transporters used and the disposal facility or facilities used for all Sharps.” A. Transporter Information See Appendix F; Transporters. B. Disposal Facility Information See Appendix G; Disposal Facilities. IX. Safety and Security Report Ordinance Sec. 6.54.120.A.8: “Whether any safety or security problems occurred during collection, transportation or disposal of Sharps during the reporting period and, if so, what changes have or will be made to policies, procedures or tracking mechanisms to alleviate the problem and to improve safety and security in the future, this portion of the report may be submitted under separate cover clearly marked ‘Safety and Security Report’.” See Appendix H; Safety and Security Report. X. Educational Efforts and Public Outreach Ordinance Sec. 6.54.120.A.9: “A description of the public education, outreach and evaluation activities implemented during the reporting period.” A. Public Education Activities MED-Project provided a variety of public education activities during the Reporting Period, including providing disposal instructions for Sharps kiosks and Mail-Back Services, maintaining a website and toll- free number that provide information on the proper disposal of Sharps waste, collection, and disposal options available through MED-Project, and providing outreach materials. The website, toll-free number, and outreach materials, such as posters and brochures, were available in English, Spanish, Chinese, 7 Tagalog, and Vietnamese. MED-Project increased public awareness of the Program in 2020 through the placement of animation advertisements on digital campaigns and the addition of video and radio public service announcements in English, Spanish, Chinese, Tagalog, and Vietnamese to the MED-Project website. MED-Project website information and statistics are provided in Appendices I and J, respectively. See Appendix K for examples of brochures and posters. See Appendix L for brochure and poster distribution information. B. Outreach Activities MED-Project conducted the following outreach activities during the Reporting Period: provided print and digital advertisement campaigns, distributed signage and/or brochures, posted information on social media sites, and sent email blasts. Examples of MED-Project's brochures and posters are provided in Appendix K and brochure and poster distribution information is provided in Appendix L. A list of social media and promotion activities is provided in Appendix M. The reach for each campaign is provided in the Media Outreach Summary. See Appendix N. C. Evaluation Activities Consistent with Ordinance Section 6.54.100.A.4, MED-Project conducted the first biennial survey in 2020. Survey results were posted to the Website on November 30, 2020. MED-Project performed a review of the survey to evaluate media and public outreach. 20% of Alameda County Residents surveyed remember having been exposed to messaging in the past year about safely storing/disposing of Sharps. 13% of those who were recently exposed to messaging saw it on television. Additionally, of those Alameda County Residents surveyed, 19% reported having used Kiosk Drop-Off Site locations, Mail-Back Services, or take-back event disposal methods to dispose of Sharps in the Past year. Kiosk Drop-Off Site locations were used by 83% of this group. Of the Alameda County Residents who have used medicine disposal programs, 64% believe that the sharps disposal program is easy to use and 61% of the same group of Residents believe locations are easy to locate. MED-Project will continue to evaluate media and public outreach as well as collect feedback by surveys in order to identify and make adjustments and improvements to the Program. Additionally, MED-Project may revise and/or add communications materials based on changes to the Plan, as needed. XI. Program Goals Ordinance Sec. 6.54.120.A.10: “A summary of the Product Stewardship Plan's goals, the degree of success in meeting those goals in the past year, and, if any goals have not been met, what effort will be made to achieve the goals in the next year.” A. Summary of Product Stewardship Plan’s Goals During the Reporting Period, Sharps kiosk implementation and collection continued and resulted in 38 active Sharps Kiosk Drop-Off Sites. MED-Project’s long-term goal is to have 55 Sharps Kiosk Drop-Off Sites within three years and continues to make progress towards this goal. Refer to Sections III and VI of this Report for specific collection information. Figure 1 shows a graphical representation of how MED- Project strove to meet service convenience and collection goals during the Reporting Period. 8 MED-Project continued collector outreach by sending letters to potential Sharps Kiosk Drop-Off Sites on September 16, 2020. MED-Project made phone calls and sent emails to eligible sites that did not respond to the letter. Eligible non-participating sites were contacted monthly until either the site began participating in the Program or the site indicated they no longer wanted to be considered for participation. MED-Project maintained a toll-free number for a call center and the MED-Project website to provide information to Residents, as well as provided information through social media postings. XII. Expenditures Ordinance Sec. 6.54.120.A.11: “The total expenditures of the Product Stewardship Plan during the reporting period.” The total Program expenditures for the Reporting Period were $475,516. 9 Figure 1: Map of Kiosk Drop-Off Sites and Household Hazardous Waste Sites 10 This page is intentionally left blank. 11 Appendix A List of Participating Producers PARENT COMPANY COMPANY Abbott Diabetes Care Abbott Diabetes Care AbbVie Inc. AbbVie Inc. Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Ceptaris Therapeutics, LLC Actelion Pharmaceuticals US, Inc. CoTherix, Inc. Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Al Jazeera Pharmaceutical Industries Ltd Al Jazeera Pharmaceutical Industries Ltd Alvogen Pharma US, Inc. Almaject, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharma USA, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Amgen Inc. Amgen Inc. Amgen Inc. Amgen USA Amgen Inc. Immunex Corporation Amgen Inc. Onyx Pharmaceuticals Amneal Pharmaceuticals LLC Amedra Laboratories LLC Amneal Pharmaceuticals LLC Impax Laboratories, Inc. Amneal Pharmaceuticals LLC Lineage Therapeutics Inc. Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. International Medication Systems, LTD Apotex Holdings, Inc. ApoPharma USA, Inc. Apotex Holdings, Inc. Apotex Corp. AstraZeneca LP AstraZeneca LP AstraZeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals LP Bausch Health Companies Bausch Health Companies Bausch Health Companies Salix Bayer HealthCare LLC Bayer HealthCare LLC Bayer HealthCare LLC Bayer HealthCare Pharmaceuticals Inc. 12 PARENT COMPANY COMPANY Bayer HealthCare LLC Bayer HealthCare Pharmaceuticals LLC Bayer Healthcare Pharmaceuticals LLC Bayer Healthcare Pharmaceuticals LLC BE Pharmaceuticals, Inc. BE Pharmaceuticals, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Biogen Inc. Biogen Inc. BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. Bristol-Myers Squibb Company Bristol-Myers Squibb Company Bristol-Myers Squibb Company Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership Bristol-Myers Squibb Company Celgene Corporation Bristol-Myers Squibb Company E.R. Squibb & Sons, LLC Bristol-Myers Squibb Company Medarex, LLC Bristol-Myers Squibb Company ZymoGenetics, Inc. CSL Behring, LLC CSL Behring, LLC Custopharm, Inc. Leucadia Pharmaceuticals Dr. Reddy's Laboratories, Inc Promius Pharma, LLC Dr. Reddy's Laboratories, Inc Dr. Reddy's Laboratories Tennessee, LLC Dr. Reddy's Laboratories, Inc Dr. Reddy's Laboratories Louisiana, LLC Dr. Reddy's Laboratories, Inc Dr. Reddy's Laboratories, Inc Eli Lilly and Company Eli Lilly and Company Eli Lilly and Company ImClone Systems, LLC EMD Serono, Inc. EMD Serono, Inc. Endo Pharmaceuticals Inc. Anchen Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. BOCA Pharmacals, Inc. Endo Pharmaceuticals Inc. DAVA Pharmaceuticals, Inc. Endo Pharmaceuticals Inc. Generics Bidco I, LLC (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Generics Bidco II, LLC (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Innoteq, Inc. (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Quartz Specialty Pharmaceuticals, LLC (d/b/a Par Pharmaceutical) 13 PARENT COMPANY COMPANY Endo Pharmaceuticals Inc. Vintage Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Vintage Pharmaceuticals, LLC (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Auxilium Pharmaceuticals, Inc. Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc. Endo Pharmaceuticals Inc. Par Pharmaceutical Companies, Inc. Endo Pharmaceuticals Inc. Par Pharmaceutical, Inc. Endo Pharmaceuticals Inc. Par Pharmaceuticals, Inc. (d/b/a Par Pharmaceutical) Endo Pharmaceuticals Inc. Par Sterile Products, LLC (d/b/a Par Pharmaceutical) Fera Pharmaceuticals, LLC Fera Pharmaceuticals, LLC Ferring Pharmaceuticals Inc. Ferring Pharmaceuticals Inc. Fresenius Kabi USA, LLC Fresenius Kabi USA, LLC GlaxoSmithKline, LLC GlaxoSmithKline, LLC GlaxoSmithKline, LLC Novartis Consumer Health, Inc. Grifols Shared Services North America Inc. Grifols Biologicals LLC Grifols Shared Services North America Inc. Grifols Therapeutics LLC Grifols Shared Services North America Inc. Instituto Grifols S.A. Grifols Shared Services North America Inc. Laboratorios Grifols S.A. Grifols Shared Services North America Inc. Talecris Biotherapeutics, Inc. Heritage Pharmaceuticals Inc. Heritage Pharmaceuticals Inc. Hikma Americas Hikma Americas Hikma International Pharmaceuticals LLC Hikma International Pharmaceuticals LLC Hikma Pharmaceuticals LLC Hikma Pharmaceuticals LLC Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Hikma Pharmaceuticals, PLC Hikma Germany - Hikma Pharma GmbH Hikma Pharmaceuticals, PLC Hikma Germany - Thymoorgan Hikma Pharmaceuticals, PLC Hikma Pharmaceutcals USA, Inc.—Non-Injectables Manufacturing Facility 14 PARENT COMPANY COMPANY Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals USA, Inc. Headquarters Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals USA, Inc.—Distribution Warehouse Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals USA, Inc.—Injectable Manufacturing Facility Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals USA, Inc.—Research & Development Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals, PLC Hikma Pharmaceuticals, PLC Hikma Saudi Arabia Hikma Portugal Hikma Portugal Horizon Therapeutics plc. Horizon Orphan LLC Horizon Therapeutics plc. Horizon Pharma USA, Inc. Horizon Therapeutics plc. Horizon Therapeutics plc. Horizon Therapeutics plc. Horizon Therapeutics, Inc. Horizon Therapeutics plc. HZNP USA, Inc. Ipsen Biopharmaceuticals, Inc Ipsen Biopharmaceuticals, Inc Johnson & Johnson Actelion Johnson & Johnson Animas Corporation Johnson & Johnson Janssen Biotech, Inc. Johnson & Johnson Johnson & Johnson Kaleo Inc. Kaleo Inc. L. Perrigo Company Athena Neurosciences, LLC L. Perrigo Company Cobrek Pharmaceuticals, Inc. L. Perrigo Company Elan Pharmaceuticals, LLC L. Perrigo Company Perrigo Florida, Inc. L. Perrigo Company L. Perrigo Company L. Perrigo Company Paddock Laboratories, LLC L. Perrigo Company Perrigo Company of Tennessee L. Perrigo Company Perrigo Corporation Designated Activity Company L. Perrigo Company Perrigo Diabetes Care LLC L. Perrigo Company Perrigo LLC L. Perrigo Company Perrigo New York, Inc. L. Perrigo Company Perrigo Pharma International Designated Activity Company 15 PARENT COMPANY COMPANY L. Perrigo Company Perrigo Pharmaceuticals Company Lifescan Global Corporation Lifescan Global Corporation LifeScan, Inc. Asahi Polyslider Co. Ltd. LifeScan, Inc. LifeScan Europe GmbH LifeScan, Inc. LifeScan, Inc. Lupin Pharmaceuticals. Inc GAVIS Pharma LLC Lupin Pharmaceuticals. Inc GAVIS Pharmaceuticals LLC Lupin Pharmaceuticals. Inc Lupin Ltd. Lupin Pharmaceuticals. Inc Lupin Pharmaceuticals, Inc. Lupin Pharmaceuticals. Inc Lupin Pharmaceuticals. Inc Lupin Pharmaceuticals. Inc Novel Laboratories Inc. McKesson Corporation Cypress Medical Products LLC MedImmune Biologics, Inc MedImmune Biologics, Inc MedImmune LLC MedImmune LLC Merck & Co., Inc. Cherokee Pharmaceutical LLC Merck & Co., Inc. Cubist Pharmaceuticals Merck & Co., Inc. Intervet, Inc., doing business as Merck Animal Health Merck & Co., Inc. Merck & Co., Inc. Merck & Co., Inc. Merck Sharp & Dohme Corp. Merck & Co., Inc. Organon Teknika Corporation, LLC Merck & Co., Inc. Organon Teknika LLC Merck & Co., Inc. Organon USA Inc. Merz North America, Inc. Merz North America, Inc. Micro Labs USA Inc Micro Labs USA Inc Mylan Inc. Mylan Institutional LLC Mylan Inc. Mylan Pharmaceuticals, Inc. Mylan Inc. Mylan Specialty L.P. Mylan Teoranta Mylan Teoranta Norbrook Laboratories Limited Norbrook Laboratories Limited Norbrook Laboratories Limited Norbrook, Inc. 16 PARENT COMPANY COMPANY Novartis Group Companies Alcon Laboratories, Inc. Novartis Group Companies Eon Labs, Inc. Novartis Group Companies Fougera Pharmaceuticals Inc. Novartis Group Companies Novartis Group Companies Novartis Group Companies Novartis Pharmaceuticals Corporation Novartis Group Companies Sandoz Inc. Novo Nordisk Inc. Novo Nordisk Inc. Novo Nordisk Inc. Novo Nordisk Pharma Inc Perrigo Company of South Carolina, Inc. Perrigo Company of South Carolina, Inc. Pfizer Inc. Greenstone LLC Pfizer Inc. Meridian Medical Technologies, Inc. Pfizer Inc. Pfizer Inc. Pharming Healthcare Inc. Pharming Healthcare Inc. Recordati Rare Diseases, Inc. Recordati Rare Diseases, Inc. Roche Holdings Genentech USA, Inc. Roche Holdings Genentech, Inc. Roche Holdings Roche Diabetes Care, Inc. Roche Holdings Roche Diagnostics Corporation Roche Holdings Roche Holdings Sanofi-Aventis US LLC. Sanofi-Aventis US LLC. Shire HGT, Inc. Shire HGT, Inc. Sun Pharmaceutical Industries, Inc. Caraco Pharma, Inc. Sun Pharmaceutical Industries, Inc. Ranbaxy Laboratories Limited Sun Pharmaceutical Industries, Inc. Sun Pharmaceutical Industries, Inc. Takeda Pharmaceuticals U.S.A., Inc. Baxalta US Inc. Takeda Pharmaceuticals U.S.A., Inc. Dyax Corporation Takeda Pharmaceuticals U.S.A., Inc. Shire Human Genetic Therapies, Inc. 17 PARENT COMPANY COMPANY Takeda Pharmaceuticals U.S.A., Inc. Shire NPS Pharmaceuticals (f/k/a NPS Pharmaceuticals, Inc.) Takeda Pharmaceuticals U.S.A., Inc. Shire Orphan Therapies Inc. Takeda Pharmaceuticals U.S.A., Inc. Shire Pharmaceuticals LLC Takeda Pharmaceuticals U.S.A., Inc. Shire ViroPharma, Inc. Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. ViroPharma Biologics Inc. Teva Pharmaceuticals USA, Inc. Teva Neuroscience Inc. Teva Pharmaceuticals USA, Inc. Teva Pharmaceuticals USA, Inc. UCB Inc UCB Inc UCB Inc. UCB Inc. United Therapeutics Corporation United Therapeutics Corporation Upsher-Smith Laboratories, LLC Upsher-Smith Laboratories, LLC US WorldMeds, LLC Solstice Neurosciences, LLC West-Ward Pharmaceuticals International Limited West-Ward Pharmaceuticals International Limited Table 1: List of Participating Producers 18 Appendix B Sharps Kiosk Collection Data The locations of Sharps collection from Kiosk Drop-Off Sites in the County during the Reporting Period. SITE ADDRESS CITY ZIP POUNDS PICK- UPS OUTER CONTAINERS Alameda Health System - San Leandro Hospital 13855 East 14th Street San Leandro 94578 427 27 27 Alameda Hospital* 2070 Clinton Avenue Alameda 94501 168 9 9 Berkeley Police Department* 2100 Martin Luther King Jr. Way Berkeley 94704 149 8 8 Capsule Pharmacy 2557 Mowry Avenue, Suite 11 Fremont 94538 688 28 28 CVS Pharmacy #00331 2000 Driscoll Road Fremont 94539 756 28 28 CVS Pharmacy #00414 14869 East 14th Street San Leandro 94578 126 9 9 CVS Pharmacy #00816 22501 Foothill Boulevard Hayward 94541 553 28 28 CVS Pharmacy #03024 7201 Regional Street Dublin 94568 1,020 28 29 CVS Pharmacy #08431 7200 Bancroft Avenue Oakland 94605 600 28 28 CVS Pharmacy #09099 4020 Fremont Hub Fremont 94538 1,157 28 29 CVS Pharmacy #09255 931 Marina Village Parkway Alameda 94501 1,030 29 28 CVS Pharmacy #09378 4100 Redwood Road Oakland 94619 937 28 28 CVS Pharmacy #09397 4405 First Street Livermore 94551 835 29 29 * Site had an access restriction due to the COVID-19 pandemic during the Reporting Period. 19 SITE ADDRESS CITY ZIP POUNDS PICK- UPS OUTER CONTAINERS CVS Pharmacy #09494 35080 Newark Boulevard Newark 94560 1,278 40 41 CVS Pharmacy #09622 243 West Jackson Street Hayward 94544 619 26 26 CVS Pharmacy #09635 1550 East 14th Street San Leandro 94577 960 27 27 CVS Pharmacy #09678 1500 First Street Livermore 94550 901 30 31 CVS Pharmacy #09876 699 Lewelling Boulevard San Leandro 94579 820 26 26 CVS Pharmacy #09904 3667 Castro Valley Boulevard Castro Valley 94546 1,074 27 29 CVS Pharmacy #09957 344 Thomas L. Berkley Way Oakland 94612 355 14 14 CVS Pharmacy #10119 6750 Bernal Avenue Pleasanton 94566 714 27 27 CVS Pharmacy #10121 2655 Telegraph Avenue Berkeley 94704 1,005 29 29 CVS Pharmacy #10199 26059 Mission Boulevard Hayward 94544 651 28 28 CVS Pharmacy #10924 3010 Bernal Avenue Pleasanton 94566 863 27 27 Haller's Pharmacy and Medical Supply* 37323 Fremont Boulevard Fremont 94536 604 20 20 Highland Hospital Outpatient Pharmacy 1411 East 31st Street Oakland 94602 569 26 26 Kaiser Permanente Dublin MOB Pharmacy #061 3100 Dublin Boulevard Floor 1 Dublin 94568 1,671 47 47 Kaiser Permanente Pharmacy #241 3000 Los Positas Livermore 94551 1,613 53 53 Kaiser Pleasanton South #471 7601 Stoneridge Pleasanton 94588 1,646 52 52 Mission Pharmacy 22138 Mission Boulevard Hayward 94541 176 8 8 * Site had an access restriction due to the COVID-19 pandemic during the Reporting Period. 20 SITE ADDRESS CITY ZIP POUNDS PICK- UPS OUTER CONTAINERS New Oakland Pharmacy - Lake Merritt 250 East 18th Street, 3rd Floor Oakland 94606 164 8 8 New Oakland Pharmacy 1 333 9th Street Oakland 94607 163 8 8 New Oakland Pharmacy 2 388 9th Street, Suite 108 Oakland 94607 653 27 27 Piedmont Police Department* 403 Highland Avenue Piedmont 94611 147 7 7 Teds Drugs 27453 Hesperian Boulevard Hayward 94545 549 26 26 Tennyson Pharmacy* 589 West Tennyson Road Hayward 94544 107 7 7 University of California (UC) Berkeley University Health Services Pharmacy* 2222 Bancroft Way Berkeley 94720 143 8 8 Wellspring Pharmacy* 4184 C Piedmont Avenue Oakland 94611 465 17 19 TOTALS 26,356 922 929 Table 2: Sharps Kiosk Collection Data * Site had an access restriction due to the COVID-19 pandemic during the Reporting Period. 21 Appendix C Sharps Household Hazardous Waste Facilities SITE ADDRESS CITY ZIP POUNDS PICK- UPS OUTER CONTAINERS Fremont Facility* 41149 Fremont Blvd Fremont 94536 4,173 24 112 Hayward Facility* 201 West Winton Ave Hayward 94545 1,629 8 45 Livermore Facility* 5584 La Ribera St Livermore 94550 2,898 10 77 Oakland* Facility 210 East 7th St Oakland 94607 4,695 10 125 TOTALS 13,395 52 359 Table 3: Sharps Household Hazardous Waste Facilities * Site had an access restriction due to the COVID-19 pandemic during the Reporting Period. 22 Appendix D Sharps Mail-Back Services The number of Sharps mail-back packages provided to Residents and returned. RESIDENTIAL MAIL-BACK SERVICES PACKAGES DISTRIBUTED PACKAGES RETURNED WEIGHT Sharps Mail-Back Packages 357 60 207.7 Table 4: Sharps Mail-Back Services 23 Appendix E Sharps Take-Back Event Sharps Take-Back Event performed during the Reporting Period. DATE SITE ADDRESS CITY POUNDS CONTAINERS 10/11/2020 Albany HHW One-Day Event 1100 Eastshore Highway Berkeley 163 5 Table 5: Sharps Take-Back Event 24 Appendix F Transporters NAME ADDRESS Clean Harbors Environmental Services 42 Longwater Drive, Norwell, MA 02061 Daniels Sharpsmart Inc. 1340 Grandview Parkway, Sturtevant, WI 53177 Medsharps, LLC 17340 Bell North Drive, Schertz, TX 78154 Sharps Solutions, LLC 3563 Investment Blvd, Suite 6, Hayward, CA 94545 Union Pacific Rail Road Company 1400 Douglas Street, Omaha, NE 68179 United States Postal Service 475 L’Enfant Plaza Southwest, Washington, DC 20260 Table 6: Transporters 25 Appendix G Disposal Facilities NAME ADDRESS American Avenue Disposal Site 18950 West American Avenue, Kerman, CA 93630 Clean Harbors – Aragonite 11600 North Aptus Road, Aragonite, UT 84029 Curtis Bay Energy, LP 3200 Hawkins Point Road, Baltimore, MD 21226 Daniels Sharpsmart Inc. 4144 East Therese Avenue, Fresno, CA 93725 Medsharps, LLC 17340 Bell North Drive, Schertz, TX 78154 Tessman Road Landfill 7000 East IH 10, San Antonio, TX 78219 Table 7: Disposal Facilities 26 Appendix H Safety and Security Report Event: Kiosk Keys Stolen During Civil Unrest Date: June 24, 2020 Description: A host site in Alameda County reported that its location was broken into during an episode of civil unrest and that the cash register containing the kiosk keys was stolen during the break in. The site did not report any damage to or tampering with the kiosk or its contents. Corrective Action Taken: The kiosk locks were replaced, rendering the stolen keys unable to open the kiosk. 27 Appendix I MED-Project Website Pages A representative sample of MED-Project website pages for the County during the Reporting Period. Figure 2: MED-Project Website Landing Page (December 2020) 28 Figure 3: MED-Project Website Check the Package Page (December 2020) 29 Figure 4: MED-Project Website Convenient Locations Page (December 2020) 30 Figure 5: MED-Project Website Mail Back Page (December 2020) 31 Figure 6: MED-Project Website Take-Back Events Page (December 2020) 32 Figure 7: MED-Project Website In-Home Disposal Page (December 2020) 33 Figure 8: MED-Project Website MEDinfo Page (December 2020) 34 Figure 9: MED-Project Website MEDfaq Page (December 2020) 35 Figure 10: MED-Project Website Contact Page (December 2020) 36 Appendix J Website Statistics The total number of website visits during the Reporting Period, by page, for both Alameda Unwanted Medicine and Sharps Programs. WEB PAGE NAME WEB PAGE URL VISITS Home Page https://med-project.org/locations/alameda/ 37,497 Convenient Locations https://med-project.org/locations/alameda/convenient-locations/ 6,870 Mail Back https://med-project.org/locations/alameda/mail-back/ 2,100 MEDinfo https://med-project.org/locations/alameda/medinfo/ 399 Contact https://med-project.org/locations/alameda/contact/ 171 MEDfaq https://med-project.org/alameda/alameda/medfaq/ 236 Check the Package https://med-project.org/locations/alameda/package/ 545 Take-Back Events https://med-project.org/locations/alameda/take-back-events/ 567 In-Home Disposal https://med-project.org/locations/alameda/disposal/ 550 Table 8: MED-Project Website Statistics 37 Appendix K MED-Project Sharps Brochures and Posters Figure 11: MED-Project Brochure Front (English) 38 Figure 12: MED-Project Brochure Back (English) 39 Figure 13: MED-Project Brochure Front (Spanish) 40 Figure 14: MED-Project Brochure Back (Spanish) 41 Figure 15: MED-Project Brochure Front (Chinese) 42 Figure 16: MED-Project Brochure Back (Chinese) 43 Figure 17: MED-Project Brochure Front (Tagalog) 44 Figure 18: MED-Project Brochure Back (Tagalog) 45 Figure 19: MED-Project Brochure Front (Vietnamese) 46 Figure 20: MED-Project Brochure Back (Vietnamese) 47 Figure 21: MED-Project Sharps Poster 48 Figure 22: MED-Project Sharps Poster (Spanish) 49 Figure 23: MED-Project Sharps Poster (Chinese) 50 Figure 24: MED-Project Sharps Poster (Tagalog) 51 Figure 25: MED-Project Sharps Poster (Vietnamese) 52 Appendix L Brochure and Poster Distribution Kiosk Drop-Off Sites that received brochures or posters during the Reporting Period. SITE ADDRESS CITY ZIP CODE CVS Pharmacy 09099 4020 Fremont Hub Fremont 94538 University of California (UC) Berkeley University Health Services Pharmacy 2222 Bancroft Way Berkeley 94720 Table 9: Brochure and Poster Distribution 53 Appendix M Social Media and Promotion Activity Social Media Posts Social media posts made during the Reporting Period. TYPE DATE SUBJECT PUBLICATION / STATION Social Media 01/02/2020 CVS Pharmacy #10924 Facebook/Twitter Social Media 01/05/2020 CVS/Pharmacy #09876 Facebook/Twitter Social Media 01/09/2020 CVS/Pharmacy #08431 Facebook/Twitter Social Media 01/12/2020 CVS/Pharmacy #08431 Facebook/Twitter Social Media 01/16/2020 CVS/Pharmacy #03024 Facebook/Twitter Social Media 01/19/2020 Kaiser Health Plan South 1 Phy 471 Facebook/Twitter Social Media 01/23/2020 General Sharps Program Information Facebook/Twitter Social Media 01/26/2020 CVS/Pharmacy #09255 Facebook/Twitter Social Media 01/30/2020 General Sharps Program Information Facebook/Twitter Social Media 02/02/2020 General Sharps Program Information Facebook/Twitter Social Media 02/06/2020 General Sharps Program Information Facebook/Twitter Social Media 02/09/2020 General Sharps Program Information Facebook/Twitter Social Media 02/13/2020 General Sharps Program Information Facebook/Twitter Social Media 02/16/2020 CVS/Pharmacy #09622 Facebook/Twitter Social Media 02/20/2020 Capsule Pharmacy Facebook/Twitter Social Media 02/23/2020 CVS/Pharmacy #10121 Facebook/Twitter Social Media 02/27/2020 Teds Drugs Facebook/Twitter Social Media 03/01/2020 General Sharps Program Information Facebook/Twitter Social Media 03/05/2020 Kaiser Permanente Pharmacy #241 Facebook/Twitter Social Media 03/08/2020 CVS Pharmacy #10924 Facebook/Twitter Social Media 03/12/2020 General Sharps Program Information Facebook/Twitter Social Media 03/15/2020 New Oakland Pharmacy #1 Facebook/Twitter Social Media 03/19/2020 CVS/Pharmacy #09957 Facebook/Twitter Social Media 03/22/2020 General Sharps Program Information Facebook/Twitter Social Media 03/26/2020 CVS/Pharmacy #09494 Facebook/Twitter Social Media 03/29/2020 General Sharps Program Information Facebook/Twitter 54 TYPE DATE SUBJECT PUBLICATION / STATION Social Media 04/02/2020 General Sharps Program Information Facebook/Twitter Social Media 04/05/2020 General Sharps Program Information Facebook/Twitter Social Media 04/09/2020 General Sharps Program Information Facebook/Twitter Social Media 04/12/2020 General Sharps Program Information Facebook/Twitter Social Media 04/16/2020 General Sharps Program Information Facebook/Twitter Social Media 04/19/2020 CVS/Pharmacy #09622 Facebook/Twitter Social Media 04/23/2020 Capsule Pharmacy Facebook/Twitter Social Media 04/26/2020 CVS/Pharmacy #10121 Facebook/Twitter Social Media 04/30/2020 Teds Drugs Facebook/Twitter Social Media 05/03/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/07/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/10/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/14/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/17/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/21/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/24/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 05/28/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/04/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/07/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/11/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/14/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/18/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter 55 TYPE DATE SUBJECT PUBLICATION / STATION Social Media 06/21/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/25/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 06/28/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/02/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/05/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/09/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/12/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/16/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/19/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/23/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/26/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 07/30/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/02/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/06/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/09/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/13/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/16/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/20/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/23/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter 56 TYPE DATE SUBJECT PUBLICATION / STATION Social Media 08/27/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 08/30/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/03/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/06/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/10/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/13/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/17/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/20/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/24/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 09/27/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/01/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/04/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/08/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/11/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/15/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/18/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/22/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/25/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 10/29/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter 57 TYPE DATE SUBJECT PUBLICATION / STATION Social Media 11/01/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/05/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/08/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/12/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/15/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/19/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/22/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/26/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 11/29/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/03/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/06/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/10/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/13/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/17/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/20/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/24/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/27/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Social Media 12/30/2020 General Unwanted Medicine/Sharps Program Information Facebook/Twitter Table 10: Social Media Posts 58 Email Blast Activity Email blasts sent to community contacts during the Reporting Period. TYPE DATE SUBJECT PUBLICATION / STATION Email Blast 05/18/20 Announce Unwanted Medicine/Sharps Disposal Program Email Email Blast 09/30/20 Announce Unwanted Medicine/Sharps Disposal Program Email Email Blast 12/30/20 Announce Unwanted Medicine/Sharps Disposal Program Email Table 11: Email Blast Activity 59 Appendix N Media Outreach Summary Outreach Activity Start Date End Date Frequency Impressions Reach (# of individuals) Digital (Multiple Publishers) 01/16/2020 02/12/2020 4.9 1,796,779 367,910 Print- Alameda Sun 02/13/2020 03/05/2020 4.0 416,000 104,000 Print- Castro Valley Forum 04/14/2020 04/22/2020 2.0 112,500 56,250 Print-San Leandro Times 04/15/2020 04/23/2020 2.0 192,500 96,250 Digital-www.eastbaytimes.com 04/17/2020 05/10/2020 1.0 100,000 100,000 Digital (Multiple Publishers) 06/22/2020 07/19/2021 2.7 1,305,253 475,183 Print-East Bay Times/Alameda Journal 08/07/2020 08/28/2020 4.0 74,924 18,731 Print-East Bay Times/ The Montclarion 08/07/2020 08/28/2020 4.0 103,672 25,918 Print-East Bay Times/The Piedmonter 08/07/2020 08/28/2020 4.0 21,088 5,272 Digital-www.eastbaytimes.com 09/06/2020 10/04/2020 1.0 100,000 100,000 Print- Castro Valley Forum 11/04/2020 11/25/2020 4.0 225,000 56,250 Print-San Leandro Times 11/05/2020 11/26/2020 4.0 385,000 96,250 Digital (Multiple Publishers) 11/23/2020 12/20/2020 4.9 3,299,576 666,747 Table 12: Media Outreach Summary